166 related articles for article (PubMed ID: 33131261)
21. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
22. Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.
Yoshida Y; Oguma S; Ohno H; Nakabo Y; Katsurada T; Kawahara M; Kawabata H
Int J Hematol; 2014 Jun; 99(6):721-5. PubMed ID: 24687918
[TBL] [Abstract][Full Text] [Related]
23. Peripheral Neuropathies Associated With Monoclonal Gammopathies.
Naddaf E; Mauermann ML
Continuum (Minneap Minn); 2020 Oct; 26(5):1369-1383. PubMed ID: 33003006
[TBL] [Abstract][Full Text] [Related]
24. Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study.
Sgherza N; Curci P; Rizzi R; Strafella V; Di Gennaro D; Vitucci A; Palma A; Rossi AVR; Albano F; Stefanizzi P; Tafuri S; Musto P
Haematologica; 2022 Feb; 107(2):555-557. PubMed ID: 34732044
[No Abstract] [Full Text] [Related]
25. Prevalence of monoclonal gammopathy of undetermined significance in US black women.
Bertrand KA; Zirpoli G; Niharika Pillalamarri B; Szalat R; Palmer JR; Kataria Y
Am J Hematol; 2022 Sep; 97(9):E341-E343. PubMed ID: 35723873
[No Abstract] [Full Text] [Related]
26. Unusual manifestation of monoclonal gammopathy of undetermined significance: a false serum creatinine elevation.
Shimamura Y; Maeda T; Ogawa Y; Nagai Y; Shinohara T; Takizawa H
CEN Case Rep; 2020 May; 9(2):109-113. PubMed ID: 31838713
[TBL] [Abstract][Full Text] [Related]
27. Polyneuropathy in paraproteinaemia.
Meier C
J Neurol; 1985; 232(4):204-14. PubMed ID: 2995596
[TBL] [Abstract][Full Text] [Related]
28. [Peripheral neuropathies associated with monoclonal gammapathies. Value of electrophysiologic studies].
Bouche P; Bouchacourt E; Leger JM; Travers MA; Cathala HP
Rev Electroencephalogr Neurophysiol Clin; 1985 Dec; 15(3):255-65. PubMed ID: 3006187
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal gammopathy and neuropathy.
Lozeron P; Adams D
Curr Opin Neurol; 2007 Oct; 20(5):536-41. PubMed ID: 17885441
[TBL] [Abstract][Full Text] [Related]
30. Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study.
Rögnvaldsson S; Aspelund T; Thorsteinsdóttir S; Turesson I; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Jul; 107(1):137-144. PubMed ID: 33840154
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal gammopathy in atomic bomb survivors.
Neriishi K; Yoshimoto Y; Carter RL; Matsuo T; Ichimaru M; Mikami M; Abe T; Fujimura K; Kuramoto A
Radiat Res; 1993 Mar; 133(3):351-9. PubMed ID: 8451386
[TBL] [Abstract][Full Text] [Related]
32. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of monoclonal gammopathy in Morocco - A hospital-based study.
Ouzzif Z; Doghmi K; Messaoudi N; Bouhsain S; El Machtani S; Biaz A; Rachid A; Dami A; Bezza A; El Maataoui A
Cancer Rep (Hoboken); 2023 May; 6(5):e1814. PubMed ID: 36999311
[TBL] [Abstract][Full Text] [Related]
34. Neuropathy and paraproteins: review of a complex association.
Rajabally YA
Eur J Neurol; 2011 Nov; 18(11):1291-8. PubMed ID: 21418441
[TBL] [Abstract][Full Text] [Related]
35. An Interference in an Automated HCO3- Assay Leads to an Unexpected IgG Monoclonal Gammopathy Diagnosis.
Nelson HA; Genzen JR; Delgado JC; Rudolf JW
J Appl Lab Med; 2022 Mar; 7(2):622-625. PubMed ID: 34849974
[No Abstract] [Full Text] [Related]
36. Paraproteinemic neuropathy.
Zivković SA; Lacomis D; Lentzsch S
Leuk Lymphoma; 2009 Sep; 50(9):1422-33. PubMed ID: 19637090
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal Gammopathies of 'Neurological Significance': Paraproteinemic Neuropathies.
Mani AM; Devasia AJ; Nair A; Benjamin RN; Prabhakar AT; Sivadasan A; Mathew V; Aaron S; George B; Alexander M
Can J Neurol Sci; 2021 Sep; 48(5):616-625. PubMed ID: 33397535
[TBL] [Abstract][Full Text] [Related]
38. The Wide Spectrum of Pathophysiologic Mechanisms of Paraproteinemic Neuropathy.
Vallat JM; Duchesne M; Corcia P; Richard L; Ghorab K; Magy L; Mathis S
Neurology; 2021 Feb; 96(5):214-225. PubMed ID: 33277411
[TBL] [Abstract][Full Text] [Related]
39. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
Derman B; Castillo JJ; Sarosiek S; Beksac M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
[TBL] [Abstract][Full Text] [Related]
40. Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
Zanwar S; Ho M; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Vincent Rajkumar S; Kumar S
Blood Cancer J; 2022 Nov; 12(11):160. PubMed ID: 36424376
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
